ストックスクリーナーアプリを入手
87.99
0.99%
0.86
アフターアワーズ：
87.99
前日終値:
$87.13
開ける：
$87.23
24時間の取引高:
1.01M
Relative Volume:
1.22
時価総額：
$9.26B
収益：
$628.56M
当期純損益:
$141.82M
株価収益率:
69.83
EPS:
1.26
ネットキャッシュフロー:
$142.60M
1週間 パフォーマンス:
+2.19%
1か月 パフォーマンス:
+12.25%
6か月 パフォーマンス:
+23.62%
1年 パフォーマンス:
+56.22%
1日の値動き範囲:
$86.13
$88.73
1週間の範囲:
$81.31
$88.73
52週間の値動き範囲:
$49.00
$117.33
Corcept Therapeutics Inc Stock (CORT) Company Profile
名前
Corcept Therapeutics Inc
セクター
電話
650.688.8803
住所
101 REDWOOD SHORES PARKWAY, REDWOOD CITY
CORT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CORT
Corcept Therapeutics Inc
|
87.99 | 9.17B | 628.56M | 141.82M | 142.60M | 1.26 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Corcept Therapeutics Inc Stock (CORT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-18 | 開始されました | Wolfe Research | Peer Perform |
| 2023-11-06 | アップグレード | Truist | Hold → Buy |
| 2023-04-11 | 開始されました | SVB Securities | Market Perform |
| 2023-04-04 | 開始されました | Piper Sandler | Overweight |
| 2023-02-15 | ダウングレード | Jefferies | Buy → Hold |
| 2022-08-01 | ダウングレード | Truist | Buy → Hold |
| 2022-07-27 | アップグレード | Jefferies | Hold → Buy |
| 2022-06-27 | 再開されました | Canaccord Genuity | Buy |
| 2022-02-02 | 開始されました | Canaccord Genuity | Buy |
| 2022-01-28 | 開始されました | Truist | Buy |
| 2020-08-05 | ダウングレード | Jefferies | Buy → Hold |
| 2019-09-24 | 開始されました | Jefferies | Buy |
| 2019-09-06 | 開始されました | H.C. Wainwright | Buy |
| 2019-02-04 | ダウングレード | B. Riley FBR | Buy → Neutral |
| 2018-08-10 | 繰り返されました | Stifel | Hold |
| 2018-05-31 | ダウングレード | Stifel | Buy → Hold |
| 2018-03-09 | 開始されました | B. Riley FBR, Inc. | Buy |
| 2017-08-31 | 開始されました | Stifel | Buy |
| 2017-02-02 | 開始されました | Ladenburg Thalmann | Buy |
| 2015-04-21 | 開始されました | FBR Capital | Outperform |
| 2014-01-13 | ダウングレード | Stifel | Buy → Hold |
| 2013-08-09 | ダウングレード | Janney | Buy → Neutral |
| 2013-08-09 | ダウングレード | Ladenburg Thalmann | Buy → Neutral |
| 2012-02-21 | 繰り返されました | JMP Securities | Mkt Outperform |
| 2010-01-06 | アップグレード | Ladenburg Thalmann | Neutral → Buy |
| 2008-07-17 | 開始されました | Rodman & Renshaw | Mkt Outperform |
| 2007-06-21 | アップグレード | Punk, Ziegel & Co | Mkt Perform → Accumulate |
すべてを表示
Corcept Therapeutics Inc (CORT) 最新ニュース
Assessing Corcept Therapeutics (CORT) Valuation as Relacorilant Nears Key PDUFA Decision and Analyst Optimism Builds - Yahoo Finance
Wall Street Firms Tout Corcept Therapeutics Incorporated (CORT) Prospects on Korlym Medication Prospects - Yahoo Finance
Analysts see 70% upside potential in Corcept Therapeutics (CORT) stock - MSN
Hsbc Holdings PLC Reduces Stock Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics Incorporated $CORT Shares Sold by American Century Companies Inc. - MarketBeat
Epoch Investment Partners Inc. Invests $56.18 Million in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept, Optime file reply for dismissing Teva's US antitrust claims - MLex
Kennedy Capital Management LLC Raises Stake in Corcept Therapeutics Incorporated $CORT - MarketBeat
Norges Bank Makes New Investment in Corcept Therapeutics Incorporated $CORT - MarketBeat
State Board of Administration of Florida Retirement System Has $4.30 Million Stock Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
Is Corcept Therapeutics Incorporated (HTD) stock a buy before new product rolloutEarnings Performance Report & Weekly High Return Stock Forecasts - Newser
Insider Selling: Corcept Therapeutics (NASDAQ:CORT) Insider Sells 20,000 Shares of Stock - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Insider Sean Maduck Sells 20,000 Shares - MarketBeat
Corcept Therapeutics (NASDAQ:CORT) Insider Sells $397,650.00 in Stock - MarketBeat
Will Corcept Therapeutics Incorporated (HTD) stock return to pre crash levelsMarket Volume Report & Free High Accuracy Swing Entry Alerts - Newser
Corcept (CORT) Up 9.2% Since Last Earnings Report: Can It Continue? - Yahoo Finance
Chief Development Officer At Corcept Therapeutics Sells $364K Of Stock - Benzinga
Is Corcept Therapeutics Incorporated (HTD) stock inflation resilient2025 Momentum Check & Fast Moving Stock Trade Plans - Newser
Shelton Capital Management Sells 125,365 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Bridge City Capital LLC Sells 22,487 Shares of Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics Insider Sold Shares Worth $1,590,490, According to a Recent SEC Filing - marketscreener.com
Corcept Therapeutics Insider Sold Shares Worth $3,190,796, According to a Recent SEC Filing - MarketScreener
Lyon of Corcept Therapeutics sells $397k in shares By Investing.com - Investing.com South Africa
Corcept Therapeutics exec William Guyer sells $1.6m in shares By Investing.com - Investing.com Canada
Officer Guyer Sells 20,000 ($1.6M) Of Corcept Therapeutics Inc [CORT] - TradingView
Lyon of Corcept Therapeutics sells $397k in shares - Investing.com
Corcept Therapeutics CEO Belanoff sells $3.19 million in stock By Investing.com - Investing.com Canada
Van Hulzen Asset Management LLC Purchases New Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
3 Growth Companies With High Insider Ownership Seeing 30% Revenue Growth - simplywall.st
Russell Investments Group Ltd. Has $13.67 Million Stake in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept Therapeutics Incorporated $CORT Shares Sold by SG Americas Securities LLC - MarketBeat
Officer Guyer Files To Sell 20,000 Of Corcept Therapeutics Inc [CORT] - TradingView
Corcept Therapeutics (CORT) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Will Corcept Therapeutics Incorporated (HTD) stock outperform global peers - Newser
Is Corcept Therapeutics Incorporated (HTD) stock undervalued at current priceMarket Risk Analysis & Low Risk Investment Opportunities - Newser
Will Korlym Continue to Drive Corcept's Top Line in 2026? - Yahoo Finance
Corcept Therapeutics Incorporated $CORT Shares Sold by Rhumbline Advisers - MarketBeat
F m Investments LLC Invests $1.61 Million in Corcept Therapeutics Incorporated $CORT - MarketBeat
Capital Fund Management S.A. Trims Stock Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
19,858 Shares in Corcept Therapeutics Incorporated $CORT Acquired by XTX Topco Ltd - MarketBeat
Cushing’s Syndrome Diagnostics and Therapeutics Market, 2034 - Global Market Insights Inc.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Is Largely Controlled by Institutional Shareholders Who Own 69% of the Company - 富途牛牛
Legal & General Group Plc Boosts Holdings in Corcept Therapeutics Incorporated $CORT - MarketBeat
Zacks Research Analysts Decrease Earnings Estimates for CORT - MarketBeat
Franklin Resources Inc. Increases Stock Position in Corcept Therapeutics Incorporated $CORT - MarketBeat
Corcept (CORT) Q3 2025 Earnings Call Transcript - The Globe and Mail
Corcept Therapeutics (NASDAQ:CORT) Insider Sells $364,050.00 in Stock - MarketBeat
Whale Trades: Will Corcept Therapeutics Incorporated stock deliver strong dividend growthJuly 2025 Chart Watch & Expert Approved Trade Ideas - moha.gov.vn
Chief Development Officer Of Corcept Therapeutics Sold $364K In Stock - Benzinga
What is Zacks Research's Forecast for CORT FY2025 Earnings? - MarketBeat
Corcept Therapeutics Incorporat (CORT) Stock Forecasts - Yahoo Finance
Corcept Therapeutics Inc (CORT) 財務データ
収益
当期純利益
現金流量
EPS
1.08%
0.91%
大文字化:
|
ボリューム (24 時間):